These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 19268538)

  • 1. Reassessment of phenytoin for treatment of late stage progressive myoclonus epilepsy complicated with status epilepticus.
    Miyahara A; Saito Y; Sugai K; Nakagawa E; Sakuma H; Komaki H; Sasaki M
    Epilepsy Res; 2009 Apr; 84(2-3):201-9. PubMed ID: 19268538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoclonic status epilepticus in juvenile myoclonic epilepsy.
    Larch J; Unterberger I; Bauer G; Reichsoellner J; Kuchukhidze G; Trinka E
    Epileptic Disord; 2009 Dec; 11(4):309-14. PubMed ID: 20045780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pediatric epilepsy: European expert opinion, 2007.
    Wheless JW; Clarke DF; Arzimanoglou A; Carpenter D
    Epileptic Disord; 2007 Dec; 9(4):353-412. PubMed ID: 18077226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam.
    Vaca GF; Lenz T; Knight EM; Tuxhorn I
    Epileptic Disord; 2012 Jun; 14(2):155-8. PubMed ID: 22569507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy.
    Thomas P; Valton L; Genton P
    Brain; 2006 May; 129(Pt 5):1281-92. PubMed ID: 16513683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The medical treatment of epilepsy: treatment of prolonged convulsions and status epilepticus.
    Livingston S; Pruce I; Pauli LL
    Pediatr Ann; 1979 Apr; 8(4):255-60. PubMed ID: 111210
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome)--a nationwide questionnaire survey in Japan.
    Tanabe T; Awaya Y; Matsuishi T; Iyoda K; Nagai T; Kurihara M; Yamamoto K; Minagawa K; Maekawa K
    Brain Dev; 2008 Nov; 30(10):629-35. PubMed ID: 18424028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive myoclonic epilepsy: A clinical, electrophysiological and pathological study from South India.
    Sinha S; Satishchandra P; Gayathri N; Yasha TC; Shankar SK
    J Neurol Sci; 2007 Jan; 252(1):16-23. PubMed ID: 17166519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eight-year study of childhood status epilepticus: midazolam infusion in management and outcome.
    Koul R; Chacko A; Javed H; Al Riyami K
    J Child Neurol; 2002 Dec; 17(12):908-10. PubMed ID: 12593465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New lessons: Classic treatments in convulsive status epilepticus.
    Renganathan R; Conlon N; Sweeney B
    Ir Med J; 2007; 100(10):618-20. PubMed ID: 18277730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myoclonic epilepsies in infancy].
    Palencia R
    Rev Neurol; 2000 Jun; 30 Suppl 1():S15-24. PubMed ID: 10904965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of convulsive status epilepticus in infants and children].
    Hubert P; Parain D; Vallée L
    Rev Neurol (Paris); 2009 Apr; 165(4):390-7. PubMed ID: 19264335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam.
    Kobayashi K; Takeuchi A; Oka M; Akiyama M; Ohtsuka Y
    Brain Dev; 2012 May; 34(5):368-71. PubMed ID: 21889282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of status epilepticus].
    Tsuji S; Akamatsu N
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1097-9. PubMed ID: 12235807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam.
    Eue S; Grumbt M; Müller M; Schulze A
    Epilepsy Behav; 2009 Aug; 15(4):467-9. PubMed ID: 19616482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic approach to non-convulsive status epilepticus in developmental period].
    Martinović Z; Jović N
    Srp Arh Celok Lek; 1994; 122(3-4):69-73. PubMed ID: 17972812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection.
    Engelsen BA; Tzoulis C; Karlsen B; Lillebø A; Laegreid LM; Aasly J; Zeviani M; Bindoff LA
    Brain; 2008 Mar; 131(Pt 3):818-28. PubMed ID: 18238797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroclinical features of epilepsy in patients with juvenile type dentatorubral-pallidoluysian atrophy.
    Egawa K; Takahashi Y; Kubota Y; Kubota H; Inoue Y; Fujiwara T; Onodera O
    Epilepsia; 2008 Dec; 49(12):2041-9. PubMed ID: 18616556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Status epilepticus in central nervous system infections: an experience from a developing country.
    Misra UK; Kalita J; Nair PP
    Am J Med; 2008 Jul; 121(7):618-23. PubMed ID: 18589058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of status epilepticus in children with epilepsy].
    Chiron C; Bahi-Buisson N; Plouin P
    Arch Pediatr; 2004 Oct; 11(10):1217-24. PubMed ID: 15475280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.